Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             36 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A clinical calculator to predict disease outcomes in women with triple-negative breast cancer Polley, Mei-Yin C.

185 3 p. 557-566
artikel
2 A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer Brezden-Masley, Christine

185 3 p. 807-815
artikel
3 A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management Shah, Hely

185 3 p. 533-547
artikel
4 Association between statin use and second cancer risk in breast cancer patients: a nationwide population-based cohort study Lu, Yin-Che

185 3 p. 773-783
artikel
5 Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis Wen, Yaokai

185 3 p. 799-806
artikel
6 Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC? Garcia-Tejedor, Amparo

185 3 p. 657-666
artikel
7 Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancer Chobrutskiy, Andrea

185 3 p. 591-600
artikel
8 Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer Dackus, Gwen M. H. E.

185 3 p. 817-830
artikel
9 Correction to: Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen Braal, C. Louwrens

185 3 p. 889
artikel
10 Correction to: Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations Katz, Matthew S.

185 3 p. 891
artikel
11 Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial Rabaglio, Manuela

185 3 p. 697-707
artikel
12 Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features Llanos, Adana A. M.

185 3 p. 785-798
artikel
13 Implant-based breast reconstruction: re-analysis of the odds ratio for skin flap necrosis Messori, Andrea

185 3 p. 887
artikel
14 Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial Raphael Daniela, D. B.

185 3 p. 685-695
artikel
15 Inflammation markers on benign breast biopsy are associated with risk of invasive breast cancer in African American women Shaik, Asra N.

185 3 p. 831-839
artikel
16 Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging? Schumacher, Katelyn

185 3 p. 567-572
artikel
17 Letter to the editor regarding the article “Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer” Chen, Xishan

185 3 p. 883
artikel
18 Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function Khoury, Katia

185 3 p. 863-868
artikel
19 Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution Li, Xiaoxian

185 3 p. 573-581
artikel
20 Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA) Clifton, Katherine

185 3 p. 639-646
artikel
21 New anti-HER2 agents for brain metastasis: histology-agnostic weapons? Tarantino, Paolo

185 3 p. 879-881
artikel
22 Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer Elsharawy, Khloud A.

185 3 p. 615-627
artikel
23 Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray Parks, R. M.

185 3 p. 647-655
artikel
24 Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase Sachdev, Jasgit C.

185 3 p. 759-771
artikel
25 Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian cancer in BRCA1/2-negative Brazilian patients Gomes, Renan

185 3 p. 851-861
artikel
26 Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial Lugtenberg, Rieneke T.

185 3 p. 741-758
artikel
27 Racial disparities in survival outcomes among breast cancer patients by molecular subtypes Zhao, Fangyuan

185 3 p. 841-849
artikel
28 Re: Naoum et al., Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy Alipour, Sadaf

185 3 p. 885-886
artikel
29 The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis Weiser, Roi

185 3 p. 667-676
artikel
30 The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements Shah, Chirag

185 3 p. 709-740
artikel
31 The RAD51D c.82G>A (p.Val28Met) variant disrupts normal splicing and is associated with hereditary ovarian cancer Yang, Ciyu

185 3 p. 869-877
artikel
32 The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer Tropée, Romain

185 3 p. 601-614
artikel
33 The wisdom trial is based on faulty reasoning and has major design and execution problems Kopans, Daniel B.

185 3 p. 549-556
artikel
34 To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis? Herbert, S. L.

185 3 p. 677-684
artikel
35 Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy Liu, Shiwei

185 3 p. 629-638
artikel
36 Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients Lattimore, Vanessa

185 3 p. 583-590
artikel
                             36 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland